Atypical Hemolytic Uremic Syndrome with Severe Extrarenal Manifestations: a Case Report
Journal of Pediatric Nephrology,
Vol. 2 No. 4 (2014),
26 October 2014
,
Page 154-157
https://doi.org/10.22037/jpn.v2i4.6738
Abstract
Atypical hemolytic uremic syndrome (aHUS) is a rare and life-threatening disease that may lead to end-stage renal failure (ESRF) or death, and may be accompanied by a variety of extrarenal manifestations. We presented a child with aHUS accompanied by severe extrarenal manifestations. A 12-year-old girl was visited in the emergency departments with acute renal failure, symptoms of fluid overload, vomiting, and somnolence. Laboratory tests revealed microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure with severe electrolyte imbalance. Diagnosis of HUS was made and emergency hemodialysis was performed to decrease the circulating volume, restore the electrolyte disturbance, and support the treatment of HUS, but conventional medical therapies were ineffective. The patient experienced frequent seizures and multiple cardiac arrests and became comatose. Thereafter, although she was diagnosed with aHUS, plasma infusions and plasmapheresis were performed. Upper gastrointestinal endoscopy and colonoscopy revealed erosive pangastritis, widespread gastric hemorrhagic ulcers, bulbitis, and hemorrhagic colitis. Since there was no improvement, the patient was transferred to a central university hospital where eculizumab was started. She responded to eculizumab. In conclusion, as aHUS can progress rapidly and is frequently fatal if untreated, it is important to be aware of unusual presentations and diagnose the condition promptly, particularly if supportive treatment is of little or no help.
How to Cite
References
Loirat C, Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 2011;6:60.
Kavanagh D, Goodship T. Genetics and complement in atypical HUS. Pediatr Nephrol 2010;25:2431–2442.
Waters AM, Licht C. aHUS caused by complement dysregulation: new therapies on the horizon. Pediatr Nephrol 2011;26:41–57.
Westra D, Wetzels JF, Volokhina EB, et al. A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome. Neth J Med 2012;70:121–129.
Campistol JM, Arias M, Ariceta G, et al. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia 2013;33:27–45.
Riedl M, Fakhouri F, Le QM, et al. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches. Semin Thromb Hemost 2014-40(4):444–64.
Meri S. Complement activation in diseases presenting with thrombotic microangiopathy. Eur J Intern Med 2013-24(6):496–502.
Mele C, Remuzzi G, Noris M. Hemolytic uremic syndrome. Semin Immunopathol 2014-36(4):399–420.
Noris M, Remuzzi G. Cardiovascular complications in atypical haemolytic uraemic syndrome. Nat Rev Nephrol 2014-10(3):174–80.
Hofer J, Rosales A, Fischer C et al. Extra-renal manifestations of complement-mediated thrombotic microangiopathies. Front. Pediatr. 2014-2:97.
Fitzpatrick MM, Walters MD, Trompeter RS, et al. Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood. J Pediatr 1993-122:532–537.
Liptakova A, Siegfried L, Rosocha J, et al. A family outbreak of haemolytic uraemic syndrome and haemorrhagic colitis caused by verocytotoxigenic Escherichia coli O157 from unpasteurized cow's milk in Slovakia. Clin Microbiol Infect 2004;10:576-578.
Ullrich S, Bremer P, Neumann-Grutzeck C, et al. Symptoms and clinical course of EHEC O104 infection in hospitalized patients: a prospective single center study. PLoS One 2013;8:e55278.
Legendre CM, Licht C, Muus P, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 2013;368:2169-2181.
Vilalta R, Lara E, Madrid A, et al. Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome. Pediatr Nephrol 2012;27:2323–2326.
Ariceta G, Besbas N, Johnson S, et al.; European Paediatric Study Group for HUS. Guideline for the investigation and initial therapy of diarrhea negative hemolytic uremic syndrome. Pediatr Nephrol 2009;24:687-696.
- Abstract Viewed: 439 times
- PDF Downloaded: 313 times